More mutations, better annotations The Fall 2019 Release of the Human Gene Mutation Database (HGMD) Professional is available, expanding the…

Investigators in the UK are using QIAGEN Clinical Insight (QCI) to identify clinically actionable mutations from blood-based sequencing results On…

We are happy to announce the Summer ’19 Release of the Human Gene Mutation Database (HGMD) Professional is now available…

We are proud to announce that QIAGEN Clinical Insight (QCI®), QIAGEN’s clinical decision support platform has achieved a milestone: over…

A high-throughput population screening laboratory sees significant scale-up with implementation of QIAGEN Clinical Insight (QCI®) INTRODUCTION Genetic disease is the leading…

Introduction to the QIAseq miRNA library kit support in the Biomedical Genomics Analysis plugin for CLC Genomics Workbench The QIAseq…

Over a quarter million germline mutations catalogued HGMD now contains 256,070 germline mutations As of March 29, 2019, HGMD contains…

As more research emerges surrounding the standardization of tumor mutational burden (TMB) assessment, a universal definition of “high TMB” across…

Sean Scott, QIAGEN’s Chief Business Officer and Vice President of Business Development for Clinical Genomics and Bioinformatics, discusses the N-of-One…

QIAGEN acquires N-of-One, expanding its clinical bioinformatics capabilities in molecular oncology decision support We are excited to announce our acquisition N-of-One,…

HGMD® Professional version 2018.4 contains a total of 248,700 mutations entries—that’s 8,431 more mutation entries than the previous release! Unlike other…

Introducing a novel myeloid gene panel for the GeneReader NGS System with integrated variant analysis, interpretation and reporting from QIAGEN…